Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04734730
Title Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Bicalutamide + Leuprolide + Prednisone + Talazoparib

Abiraterone + Goserelin + Prednisone + Talazoparib

Abiraterone + Degarelix + Prednisone + Talazoparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.